Ketamine, TMS, Psychedelics & Neuroplasticity: What the Evidence Shows

Ketamine, TMS and classic psychedelics are often grouped as plasticity-based treatments. Their clinical evidence differs greatly, and so does their regulatory status. Plasticity mechanisms are the leading explanation for several of them, but in humans the chain from molecular or network change to clinical improvement is not established. This page is educational and is not treatment advice.

Educational content only - not medical advice. In a crisis, call or text 988 (US) or your local emergency number. See crisis resources.